Dr. Tara Castellano
Claim this profileUniversity Medical Center New Orleans
Studies Endometrial Cancer
Studies Uterine Cancer
8 reported clinical trials
20 drugs studied
Area of expertise
1Endometrial Cancer
Stage I
Stage II
HER2 positive
2Uterine Cancer
Stage I
HER2 positive
Stage II
Affiliated Hospitals
Clinical Trials Tara Castellano is currently running
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting1 award Phase 2 & 310 criteria
Selinexor Maintenance Therapy
for Endometrial Cancer
The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial carcinoma (EC), who have achieved a partial response (PR) or complete response (CR) (per Response Evaluation Criteria in Solid Tumors version 1.1 \[RECIST v 1.1\]) after completing at least 12 weeks of platinum-based therapy. A total of 276 participants will be enrolled in the study and randomized in a 1:1 ratio to maintenance therapy with either selinexor or placebo.
Recruiting1 award Phase 32 criteria
More about Tara Castellano
Clinical Trial Related3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Tara Castellano has experience with
- Carboplatin
- Paclitaxel
- Trastuzumab
- Pertuzumab
- Bilateral Salpingectomy With Oophorectomy
- Bilateral Salpingectomy
Breakdown of trials Tara Castellano has run
Endometrial Cancer
Uterine Cancer
Endometrial Adenocarcinoma
Uterine Carcinosarcoma
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tara Castellano specialize in?
Tara Castellano focuses on Endometrial Cancer and Uterine Cancer. In particular, much of their work with Endometrial Cancer has involved Stage I patients, or patients who are Stage II.
Is Tara Castellano currently recruiting for clinical trials?
Yes, Tara Castellano is currently recruiting for 6 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Tara Castellano has studied deeply?
Yes, Tara Castellano has studied treatments such as Carboplatin, Paclitaxel, Trastuzumab.
What is the best way to schedule an appointment with Tara Castellano?
Apply for one of the trials that Tara Castellano is conducting.
What is the office address of Tara Castellano?
The office of Tara Castellano is located at: University Medical Center New Orleans, New Orleans, Louisiana 70112 United States. This is the address for their practice at the University Medical Center New Orleans.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.